Aurora B kinase inhibitor AZD1152: determinants of action and ability to enhance chemotherapeutics effectiveness in pancreatic and colon cancer

Aurora-C: The youngest of "The Three (Aurora kinase) Tenors" of mitotic symphony

(2011) Subrata Sen   CELL CYCLE

Aurora kinase B, epigenetic state of centromeric heterochromatin and chiasma resolution in oocytes

(2010) E Vogt et al.   REPRODUCTIVE BIOMEDICINE ONLINE

Recent developments in palliative chemotherapy for locally advanced and metastatic pancreas cancer

(2010) Soley Bayraktar   WORLD JOURNAL OF GASTROENTEROLOGY

AZD1152 Rapidly and Negatively Affects the Growth and Survival of Human Acute Myeloid Leukemia Cells In vitro and In vivo

(2009) A. Oke et al.   CANCER RESEARCH

The Topoisomerase I Poison CPT-11 Enhances the Effect of the Aurora B Kinase Inhibitor AZD1152 both In vitro and In vivo

(2009) J. S. Nair et al.   CLINICAL CANCER RESEARCH

Aurora A, centrosome structure, and the centrosome cycle

(2009) Kara B. Lukasiewicz et al.   ENVIRONMENTAL AND MOLECULAR MUTAGENESIS

Aurora kinase inhibitors in preclinical and clinical testing

(2009) Chun Hei Antonio Cheung et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

The selective Aurora B kinase inhibitor AZD1152 as a novel treatment for hepatocellular carcinoma

(2009) Arihiro Aihara et al.   JOURNAL OF HEPATOLOGY

Analysis of Aurora B kinase in non-Hodgkin lymphoma

(2009) Takayuki Ikezoe et al.   LABORATORY INVESTIGATION

Aurora B Kinase Regulates the Postmitotic Endoreduplication Checkpoint via Phosphorylation of the Retinoblastoma Protein at Serine 780

(2009) Jayasree S. Nair et al.   MOLECULAR BIOLOGY OF THE CELL

Pancreatic cancer: molecular pathogenesis and new therapeutic targets

(2009) Han H. Wong et al.   Nature Reviews Gastroenterology & Hepatology

Clinical Experience with Aurora Kinase Inhibitors: A Review

(2009) D. S. Boss et al.   ONCOLOGIST

Antiangiogenic and anticolorectal cancer effects of metronomic irinotecan chemotherapy alone and in combination with semaxinib

(2008) G Bocci et al.   BRITISH JOURNAL OF CANCER

The selective Aurora B kinase inhibitor AZD1152 is a potential new treatment for multiple myeloma

(2008) Robert P. Evans et al.   BRITISH JOURNAL OF HAEMATOLOGY

Effects of the aurora kinase inhibitors AZD1152-HQPA and ZM447439 on growth arrest and polyploidy in acute myeloid leukemia cell lines and primary blasts

(2008) E. Walsby et al.   HAEMATOLOGICA

Preclinical evaluation of M30 and M65 ELISAs as biomarkers of drug induced tumor cell death and antitumor activity

(2008) J. Cummings et al.   MOLECULAR CANCER THERAPEUTICS

Prolonged Versus Standard Gemcitabine Infusion: Translation of Molecular Pharmacology to New Treatment Strategy

(2008) S. A. Veltkamp et al.   ONCOLOGIST

Oxaliplatin retains HMGB1 intranuclearly and ameliorates collagen type II-induced arthritis

(2008) Therese Ostberg et al.   ARTHRITIS RESEARCH & THERAPY

Systemic and targeted therapy for advanced colon cancer

(2008) Sanjay R Hegde et al.   Expert Review of Gastroenterology & Hepatology

Synergic antiproliferative and antiangiogenic effects of EGFR and mTor inhibitors on pancreatic cancer cells

(2007) Amalia Azzariti et al.   BIOCHEMICAL PHARMACOLOGY